
TOLREMO therapeutics raises USD 39 Mio. Series A Financing round
by Tech Park Basel
TOLREMO therapeutics has completed its Series A financing, bringing the total amount raised to USD 39 million (CHF 34.1 million). BioMedPartners AG led the round with participation from a new investor, Pierre Fabre Invest, and existing investors...